Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.9
4.9
Journals
Pharmaceutics
Special Issues
Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery,...
share announcement

Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery, and Biological Activity

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 12430

Special Issue Editors

Prof. Dr. Kristina Ramanauskienė

E-Mail Website
Guest Editor
Department of Clinical Pharmacy, Faculty of Pharmacy, Lithuanian University of Health Sciences, Sukileliai Avenue 13, LT-50161 Kaunas, Lithuania
Interests: natural compounds; plant extract; analytical chemistry; pharmaceutical development; drug delivery
Prof. Dr. Daiva Majienė

E-Mail Website
Guest Editor
11 Laboratory of Biochemistry, Neuroscience Institute, Lithuanian University of Health Sciences, Eiveniu Str. 4, LT-50162 Kaunas, Lithuania
2. Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences, Sukileliu St. 13, LT-50162 Kaunas, Lithuania
Interests: phenolic compounds; antioxidants; antimicrobial; anticancer; in vitro
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, there has been an increasing focus on biologically active compounds due to their antimicrobial, anti-inflammatory and antioxidant activity. Products of natural origin are produced and used in various dosage forms depending on the intended use. Natural active compounds often have poor solubility, which can limit their use in the manufacture of pharmaceutical products. The isolation of biologically active compounds from plant material and the improvement of their solubility for efficient application in the production of pharmaceutical forms is one of the important scientific challenges of today. Proper solvent selection and extraction methods can improve the solubility of biologically active compounds. Environment- and human-friendly technologies are increasingly being used to extract biologically active compounds from plant-based raw materials.

This Special Issue aims to obtain up-to-date data on methods for the extraction and quality analysis of biologically active compounds, their biological activity, incorporation into pharmaceutical forms, and in vitro release studies of active compounds.

We invite scientists to submit their original research or review articles for this Special Issue, which will represent a collection of current research on phenolic compounds recovered from plants and their potential application in pharmaceuticals.

We look forward to receiving your contributions.

Prof. Dr. Kristina Ramanauskienė
Prof. Dr. Daiva Majienė
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioactive compounds
  • phenolic compounds
  • pharmaceutical development
  • natural extracts
  • in vitro
  • phytochemical characterization
  • pharmacological activity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (4 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

18 pages, 3723 KiB  
Article
Chemical Composition and Insulin-Resistance Activity of Arginine-Loaded American Cranberry (Vaccinium macrocarpon Aiton, Ericaceae) Leaf Extracts
by Oleh Koshovyi, Inna Vlasova, Heleriin Laur, Ganna Kravchenko, Oksana Krasilnikova, Sebastian Granica, Jakub P. Piwowarski, Jyrki Heinämäki and Ain Raal
Pharmaceutics 2023, 15(11), 2528; https://doi.org/10.3390/pharmaceutics15112528 - 25 Oct 2023
Cited by 7 | Viewed by 1719
Abstract
One of the key pathogenetic links in type 2 diabetes mellitus (T2DM) is the formation of insulin resistance (IR). Besides a wide selection of synthetic antidiabetic drugs, various plant-origin extracts are also available to support the treatment of T2DM. This study aimed to [...] Read more.
One of the key pathogenetic links in type 2 diabetes mellitus (T2DM) is the formation of insulin resistance (IR). Besides a wide selection of synthetic antidiabetic drugs, various plant-origin extracts are also available to support the treatment of T2DM. This study aimed to investigate and gain knowledge of the chemical composition and potential IR correction effect of American cranberry (Vaccinium macrocarpon Aiton) leaf extracts and formulate novel 3D-printed oral dosage forms for such extracts. The bioactivity and IR of L-arginine-loaded cranberry leaf extracts were studied in vivo in rats. The cranberry leaf extracts consisted of quinic, 3-caffeoylquinic (chlorogenic), p-coumaroylquinic acids, quercetin 3-O-galactoside, quercetin-3-O-glucoside, quercetin-3-xyloside, quercetin-3-O-arabino pyranoside, quercetin-3-O-arabinofuranoside, quercetin 3-O-rhamnoside, and quercetin-O-p-coumaroyl hexoside-2 identified by HPLC. In vivo studies with rats showed that the oral administration of the cranberry leaf extracts had a positive effect on insulin sensitivity coefficients under the insulin tolerance test and affected homeostasis model assessment IR levels and liver lipid content with experimental IR. A novel 3D-printed immediate-release dosage form was developed for the oral administration of cranberry leaf extracts using polyethylene oxide as a carrier gel in semi-solid extrusion 3D printing. In conclusion, American cranberry leaf extracts loaded with L-arginine could find uses in preventing health issues associated with IR. Full article
(This article belongs to the Special Issue Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery, and Biological Activity)
►▼ Show Figures

Graphical abstract

19 pages, 2045 KiB  
Article
Dermal Delivery of Korean Red Ginseng Extract: Impact on Storage Stability of Different Carrier Systems and Evaluation of Rg1 and Rb1 Skin Permeation Ex Vivo
by Victoria Klang, Eva-Maria Schweiger, Simone Strohmaier, Verena Ina Walter, Zorana Dekic and Ammar Tahir
Pharmaceutics 2023, 15(1), 56; https://doi.org/10.3390/pharmaceutics15010056 - 24 Dec 2022
Cited by 4 | Viewed by 3210
Abstract
The root extract of Panax ginseng C.A. Meyer (Korean red ginseng/KRG extract) is a traditional Asian remedy introduced to dermal products for its antioxidative potential. However, little is known about technological aspects or skin penetration of main ginsenosides. Thus, stable oil-in-water nanoemulsions (NEs) [...] Read more.
The root extract of Panax ginseng C.A. Meyer (Korean red ginseng/KRG extract) is a traditional Asian remedy introduced to dermal products for its antioxidative potential. However, little is known about technological aspects or skin penetration of main ginsenosides. Thus, stable oil-in-water nanoemulsions (NEs) and hydrogels for dermal delivery of KRG extract were developed and characterised using light scattering methods, analysis of flow properties and pH measurements. In addition, Rg1 and Rb1 contents were monitored by UHPLC/MS. Different surfactants (phosphatidylcholine, monoacylphosphatidylcholine and polysorbate 80) and polymers (polyacrylic acid and hydroxyethylcellulose) were tested and compared for their compatibility with KRG extract. The results showed that incorporation of KRG extract led to a significantly reduced formulation pH in hydroxyethylcellulose gels (−22%), NEs (−15%) and carbomer gels (−4–5%). The dynamic viscosity was in the range of 24–28 Pas at 10 s−1 for carbomer gels. The highest storage stability and skin permeation were observed for a hydroalcoholic gel with carbomer 50,000 and TRIS buffer (each of 1% w/w), containing ethanol (20% w/w) and KRG extract (2% w/w). Ex vivo diffusion cell studies confirmed skin permeation of the moderately lipophilic Rg1, but not the more hydrophilic Rb1 with a larger molecular weight. Full article
(This article belongs to the Special Issue Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery, and Biological Activity)
►▼ Show Figures

Figure 1

15 pages, 3553 KiB  
Article
Comparison of the Formulation, Stability and Biological Effects of Hydrophilic Extracts from Black Elder Flowers (Sambucus nigra L.)
by Aurelijus Laurutis, Julius Liobikas, Monika Stanciauskaite, Mindaugas Marksa, Kristina Ramanauskiene and Daiva Majiene
Pharmaceutics 2022, 14(12), 2831; https://doi.org/10.3390/pharmaceutics14122831 - 16 Dec 2022
Cited by 5 | Viewed by 1823
Abstract
Elderflower preparations have long been used to treat colds and flu, but their use is undeservedly reduced, and only dried flower teas, less often ethanolic extracts, can be purchased in pharmacies. In the case of homemade teas, the medicinal plant material is extracted [...] Read more.
Elderflower preparations have long been used to treat colds and flu, but their use is undeservedly reduced, and only dried flower teas, less often ethanolic extracts, can be purchased in pharmacies. In the case of homemade teas, the medicinal plant material is extracted with hot water for a relatively short time, thus only a small part of the active substances is extracted. The industrially produced ethanolic extract is rich in active substances, but its use is limited since ethanol in many countries is undesirable and unsuitable for children and geriatric patients. Therefore, the aim of this work was to produce extracts from elder flowers using water as extractant and a mixture of water + polyethylene glycol (PEG) 20%, to compare their chemical composition and stability, and to study the ability to neutralize reactive oxygen species (ROS) and to sustain the viability of C6 glial cells under oxidative stress conditions. The ethanolic extract was used as a standard. Thus, the extract with PEG contained more than two times higher amount of total phenolics (PC) than the aqueous one, and the stability at 6–8 °C was comparable to the stability of ethanolic extract. All three extracts showed an antioxidant effect in a concentration-dependent manner in vitro. However, only the PEG containing extract (at 20–40 µg/mL PC) was the most effective in reducing the intracellular level of ROS and sustaining the viability of glial cells. The results suggest that the co-solvent PEG increases the yield of phenolics in the extract, prolongs the stability, and enhances positive biological effects. Full article
(This article belongs to the Special Issue Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery, and Biological Activity)
►▼ Show Figures

Figure 1

Review

Jump to: Research

57 pages, 4701 KiB  
Review
Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes
by Guannan He, Guangfeng Chen, Weidong Liu, Dongxue Ye, Xuehuan Liu, Xiaodong Liang and Jing Song
Pharmaceutics 2023, 15(9), 2235; https://doi.org/10.3390/pharmaceutics15092235 - 29 Aug 2023
Cited by 47 | Viewed by 4612
Abstract
Salvianolic acid B is extracted from the roots and rhizomes of Danshen (Salvia miltiorrhiza Bge., family Labiatae). It is a water-soluble, weakly acidic drug that has demonstrated antitumor and anti-inflammatory effects on various organs and tissues such as the lung, heart, kidney, [...] Read more.
Salvianolic acid B is extracted from the roots and rhizomes of Danshen (Salvia miltiorrhiza Bge., family Labiatae). It is a water-soluble, weakly acidic drug that has demonstrated antitumor and anti-inflammatory effects on various organs and tissues such as the lung, heart, kidney, intestine, bone, liver, and skin and protective effects in diseases such as depression and spinal cord injury. The mechanisms underlying the protective effects of salvianolic acid B are mainly related to its anti-inflammatory, antioxidant, anti- or pro-apoptotic, anti- or pro-autophagy, anti-fibrotic, and metabolism-regulating functions. Salvianolic acid B can regulate various signaling pathways, cells, and molecules to achieve maximum therapeutic effects. This review summarizes the safety profile, combination therapy potential, and new dosage forms and delivery routes of salvianolic acid B. Although significant research progress has been made, more in-depth pharmacological studies are warranted to identify the mechanism of action, related signaling pathways, more suitable combination drugs, more effective dosage forms, and novel routes of administration of salvianolic acid B. Full article
(This article belongs to the Special Issue Unlocking the Potential of Natural Products—Advances in Drug Formulation, Delivery, and Biological Activity)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-4
Back to TopTop